Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial

BACKGROUND: Despite paucity of data, it is common practice to discontinue metformin before invasive coronary angiography due to an alleged risk of Metformin-Associated Lactic Acidosis (M-ALA). We aimed at assessing the safety of metformin continuation in diabetic patients undergoing coronary angiogr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiarito, Mauro, Sanz-Sanchez, Jorge, Piccolo, Raffaele, Condello, Francesco, Liccardo, Gaetano, Maurina, Matteo, Avvedimento, Marisa, Regazzoli, Damiano, Pagnotta, Paolo, Garcia-Garcia, Hector M., Mehran, Roxana, Federici, Massimo, Condorelli, Gianluigi, Diez Gil, Jose Luis, Reimers, Bernhard, Ferrante, Giuseppe, Stefanini, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902064/
https://www.ncbi.nlm.nih.gov/pubmed/36747244
http://dx.doi.org/10.1186/s12933-023-01744-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902064/
https://www.ncbi.nlm.nih.gov/pubmed/36747244
http://dx.doi.org/10.1186/s12933-023-01744-4

Ejemplares similares